Bardin Hill Management Partners’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-388,022
| Closed | -$268K | – | 112 |
|
|
2020
Q4 | $268K | Sell |
388,022
-204,707
| -35% | -$141K | 0.06% | 38 |
|
|
2020
Q3 | $1.33M | Sell |
592,729
-77,081
| -12% | -$173K | 0.35% | 30 |
|
|
2020
Q2 | $2.4M | Buy |
669,810
+249,032
| +59% | +$892K | 0.88% | 18 |
|
|
2020
Q1 | $1.6M | Buy |
420,778
+341,625
| +432% | +$1.3M | 0.35% | 26 |
|
|
2019
Q4 | $238K | Buy |
+79,153
| New | +$238K | 0.04% | 30 |
|